TCT 1249: First-in-Human Study of Coronary Cryotherapy for Stabilization of High-Risk Atherosclerotic Plaques
We Recommend
Disclosures
<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Grant Support/Research Contract - Abbott; Boston Scientific Corporation; Shockwave Medical; Insight Lifetech; HeartFlow; Medis Medical Imaging</li><li>Consultant Fee/Honoraria/Speaker’s Bureau - Insight Lifetech; Abbott; Boston Scientific Corporation; HeartFlow</li></ul>